Your email has been successfully added to our mailing list.

×
0 0 -0.0254237288135592 -0.101694915254237 -0.101694915254237 -0.0847457627118643 -0.0423728813559321 -0.0720338983050847
Stock impact report

Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR

Equillium, Inc. (EQ) 
Last equillium, inc. earnings: 3/26 04:07 pm Check Earnings Report
Company Research Source: Business Wire
Itolizumab was associated with high clinical response rates at Day 15 and 29?Responders were able to taper steroids by 70% at Day 29 and 99% at Day 169?Itolizumab being evaluated in pivotal Phase 3 EQUATOR study in first-line acute graft-versus-host disease LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that an oral presentation was given yesterday afternoon at the Tandem Meetings of the American Society of Transplantation and Cellular Therapy, and the Center for International Blood & Marrow Transplant Research.The oral presentation, given by Dr. John Koreth, associate professor of medicine, Dana Farber Cancer Institute, Harvard Medical School, highlights positive final study results, including long-term follow-up data for up to one year, from EQUATE (NCT03763318), a Phase 1b study of itolizumab in combination with Show less Read more
Impact Snapshot
Event Time:
EQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
EQ alerts

from News Quantified
Opt-in for
EQ alerts

from News Quantified